Barbara Buttin MD
Gynecologic Oncology
Associate Clinical Professor, Department of Surgery, City of Hope
Join to View Full Profile
Cancer Treatment Centers of America2520 Elisha AvenueZion, IL 60099
Phone+1 800-322-9183
Fax+1 630-933-4959
Dr. Buttin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Gynecologic Oncology, 2005- Washington University/B-JH/SLCH ConsortiumResidency, Obstetrics and Gynecology, 1998 - 2002
- Washington University/B-JH/SLCH ConsortiumInternship, Obstetrics and Gynecology, 1998 - 1999
Drexel University College of MedicineClass of 1998
Certifications & Licensure
IL State Medical License 2005 - 2026
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
Publications & Presentations
PubMed
- Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with d...Dana M Chase, Jørn Herrstedt, Eirwen M Miller, Lucy Gilbert, Oleksandr Zub
International Journal of Gynecological Cancer. 2025-08-01 - 1 citationsCorrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hot...Alessandro D. Santin, Virginia L. Filiaci, Stefania Bellone, Roisin E. O'Cearbhaill, Elena Ratner
Gynecologic Oncology Reports. 2020-05-28 - 12 citationsPhase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: ...Alessandro D. Santin, Virginia L. Filiaci, Stefania Bellone, Elena Ratner, Cara Mathews
Gynecologic Oncology Reports. 2020-01-02
Press Mentions
Omicron Variant Makes Itself Known over Holiday Weekend • Systems Partner to Promote Health Care Careers • NorthShore Program Encourages Genetic ScreeningNovember 29th, 2021- Dr. Barbara Buttin Joins Impressive Roster of Specialty Physicians at Cancer Treatment Centers of America in ZionNovember 18th, 2021
- Are Oncologists Any Better at Facing Their Own Mortality?November 3rd, 2021
Professional Memberships
- Fellow
- Society of Gynecologic OncologyMember
Other Languages
- French, German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
